Key result
Expressive suppression significantly moderated the relation between depressive symptoms and vagally-mediated heart rate variability (b = -0.03, p = .012), potentiating the negative association.
Why the study?
Reduced vmHRV links depression to CHD and indexes emotion dysregulation, but the moderating role of expressive suppression in the relationship between depression and vmHRV in CHD patients was unclarified.
Cross-Sectional (n=235)
No
Effect estimate: b = -0.03
p-value: p=0.012
In patients with coronary heart disease, the use of expressive suppression as an emotion regulation strategy exacerbates the negative association between depressive symptoms and vagally mediated heart rate variability.
Expressive suppression may worsen depression-vmHRV links in CHD; hypothesis-generating for prospective emotion-regulation trials, should not yet change practice.
OBJECTIVE: Poor vagally mediated heart rate variability (vmHRV) is a mechanism linking depression to coronary heart disease (CHD). Reduced vmHRV is also considered an index of emotion dysregulation-the frequent use of maladaptive emotion regulation strategies, one of the most important being expressive suppression-which is a key component of depression. Therefore, this study aimed to investigate the moderating role of expressive suppression in the relation between depression and vmHRV in patients with CHD. METHODS: The sample included 235 patients with CHD (mean [standard deviation] age = 61.6 [9.8] years; 12% women) admitted to cardiac rehabilitation after a cardiac intervention. The Beck Depression Inventory-II was administered to assess depressive symptoms. Emotion regulation strategies based on either expressive suppression or cognitive reappraisal were assessed through the Emotion Regulation Questionnaire. Resting electrocardiographic recordings were collected for 5 minutes to compute HRV indices. RESULTS: Expressive suppression moderated the relation between depressive symptoms and vmHRV ( b = -0.03, p = .012). Patients with lower expressive suppression scores showed no association between depressive symptoms and vmHRV ( b = -0.00, p = .94), whereas those with higher expressive suppression scores showed a significant negative association between depressive symptoms and vmHRV ( b = -0.05, p = .015). CONCLUSIONS: The use of expressive suppression is likely to potentiate the relation between depressive symptoms and poor vmHRV, which could increase the cardiac risk in these patients. Targeting emotion regulation skills in cardiac rehabilitation programs may be useful for reducing the impact of depression in cardiac patients.
No takes yet. Share an insight, caveat, or question.
Mura et al. (2022) conducted a cross-sectional in Coronary Heart Disease (n=235). Expressive suppression (emotion regulation strategy) vs. Low expressive suppression was evaluated on Moderation of the relation between depressive symptoms and vagally-mediated heart rate variability (vmHRV) (b = -0.03, p=0.012). Expressive suppression significantly moderated the relation between depressive symptoms and vagally-mediated heart rate variability (b = -0.03, p = .012), potentiating the negative association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: